• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Where Executives Are Doubling Down on Their Companies' Fortunes

    5/6/26 8:35:00 AM ET
    $NTHI
    $NWBI
    $RIVN
    $SRAD
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Major Banks
    Finance
    Get the next $NTHI alert in real time by email

    DENVER, May 06, 2026 (GLOBE NEWSWIRE) -- 24/7 Market News and NeOnc Technology -- As market participants are sifting through data, one signal often cuts through the noise: insiders putting real money to work. Executives and strategic stakeholders have been accumulating shares in meaningful size, ranging from six-figure buys to billion-dollar commitments. While insider buying is never a guarantee of upside, it frequently reflects conviction rooted in operational visibility, upcoming catalysts, or perceived undervaluation.

    Here's a closer look at five companies where insider activity is turning heads, and potentially signaling deeper narratives unfolding beneath the surface.

    NeOnc Technologies Holdings (NASDAQ:NTHI)

    A clinical-stage biotech focused on central nervous system cancers, NeOnc is developing intranasal delivery platforms designed to bypass the blood-brain barrier, one of the biggest challenges in oncology. Its lead candidate, NEO100, is currently in a fully enrolled Phase 2a trial targeting aggressive brain tumors such as glioblastoma, with interim data expected in the near term. The company is also advancing NEO212, a hybrid molecule with potential applications across multiple CNS malignancies.

    Insider Activity: CEO, Chairman, and President Amir Heshmatpour has been consistently buying shares on the open market, with recent purchases exceeding $500,000 and nearly $1,000,000 in cumulative insider buying over the past year. This level of repeat buying, particularly ahead of a clinical catalyst, suggests strong internal confidence in upcoming data and the broader platform's potential, including possible expansion into other neurological indications beyond oncology.

    Rivian Automotive (NASDAQ:RIVN)

    Rivian continues to position itself as a premium EV manufacturer focused on adventure vehicles, including the R1T pickup and R1S SUV, while also scaling its commercial delivery van business. The company remains in a capital-intensive growth phase, balancing production ramp challenges with long-term ambitions in software-defined vehicles and vertically integrated manufacturing.

    Insider Activity: A major recent development saw strategic partner Volkswagen commit approximately $1 billion in share purchases. While not a traditional insider buy by management, this type of large-scale strategic investment functions similarly, signaling long-term alignment and confidence in Rivian's technology stack, platform scalability, and future market share in the EV ecosystem.

    Sportradar Group (NASDAQ:SRAD)

    Sportradar operates at the intersection of sports, data, and betting, providing real-time analytics, integrity services, and AI-driven insights to leagues, sportsbooks, and media companies worldwide. As sports betting legalization expands globally, Sportradar is increasingly positioned as a foundational data infrastructure provider.

    Insider Activity: Senior executives, including the CEO, recently acquired more than $4.7 million in shares. This coordinated buying activity stands out not just for its size, but for its timing, suggesting leadership sees continued growth momentum in data monetization, AI integration, and global betting market expansion.

    Northwest Bancshares (NASDAQ:NWBI)

    Northwest Bancshares operates as a regional banking institution offering a full suite of financial services, including commercial lending, consumer banking, and wealth management. Like many regional banks, it has faced macro pressure tied to interest rates and deposit competition.

    Insider Activity: A cluster of insider purchases totaling roughly $200,000 has emerged in recent weeks. While smaller in scale than others on this list, the coordinated nature of buying across executives and directors may indicate confidence in balance sheet stability, loan portfolio quality, and potential upside as rate conditions stabilize.

    Investor Takeaway

    Insider buying is one signal among many and doesn't guarantee performance, but can become a massive narrative shift. When executives deploy meaningful personal capital, especially ahead of catalysts or during periods of uncertainty, it often reflects a level of conviction that external investors don't have access to.

    Disclaimer: This content is for informational purposes only and is not financial advice. Investors should conduct independent research, review SEC Form 4 filings via EDGAR or platforms like OpenInsider, and consult with a qualified financial advisor before making investment decisions.

    About 24/7 Market News

    In today's fast-moving markets, visibility is everything and 24/7 Market News (24/7) provides a powerful suite of investor relations and public relations solutions designed to elevate your company's profile quickly and effectively. Whether you're an established name seeking broader awareness, or a micro-cap looking to break out of obscurity, 24/7 delivers targeted, high-impact coverage through timely news distribution, analyst report placements, featured editorials, and multi-channel amplification across financial platforms, social media, and investor communities. Our services help cut through the noise, attract institutional interest, drive exposure, and build long-term shareholder credibility, all while maintaining full SEC compliance and transparency. For Analyst Report coverage, custom IR campaigns, press release syndication, or other tailored investor and public relations solutions, contact sales@247marketnews.com to discuss how 24/7 can help accelerate your company's visibility and valuation trajectory.

    PAID EDITORIAL DISCLOSURE: This is an editorial communication intended for informational purposes only. 24/7 is a third-party media provider that has not been compensated by any of the companies mentioned in this editorial, but may be compensated by NTHI for providing ongoing market outreach and other services.. This press release may include technical analysis and should not be construed as financial or investment advice. Trading stocks involves risks, and readers should consult with their financial advisor before making investment decisions.

    For further information, please visit 247marketnews.com.

    CONTACT:

    24/7 Market News

    Editor@247marketnews.com

    Cautionary Note Regarding Forward-Looking Statements

    This press release contains forward-looking statements that are subject to various risks and uncertainties. Such statements include statements regarding the Company's ability to grow its business and other statements that are not historical facts, including statements which may be accompanied by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential" or similar words. Actual results could differ materially from those described in these forward-looking statements due to a number of factors, including without limitation, the Company's ability to continue as a going concern, general economic conditions, and other risk factors detailed in the Company's filings with the SEC. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake any responsibility to update such.



    Primary Logo

    Get the next $NTHI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $NTHI
    $NWBI
    $RIVN
    $SRAD

    CompanyDatePrice TargetRatingAnalyst
    Sportradar Group AG
    $SRAD
    5/27/2026$16.00Overweight → Neutral
    Analyst
    NeOnc Technologies Holdings Inc.
    $NTHI
    5/19/2026$13.00Buy
    Alliance Global Partners
    NeOnc Technologies Holdings Inc.
    $NTHI
    5/18/2026$20.00Buy
    Maxim Group
    Northwest Bancshares Inc.
    $NWBI
    4/29/2026$14.00 → $15.00Market Perform
    Hovde Group
    NeOnc Technologies Holdings Inc.
    $NTHI
    4/24/2026$15.00Buy
    BTIG Research
    Sportradar Group AG
    $SRAD
    4/24/2026$14.00Buy → Hold
    Jefferies
    Rivian Automotive Inc.
    $RIVN
    4/1/2026$14.00Underperform → Neutral
    DA Davidson
    Rivian Automotive Inc.
    $RIVN
    3/10/2026$20.00Hold → Buy
    TD Cowen
    More analyst ratings

    $NTHI
    $NWBI
    $RIVN
    $SRAD
    SEC Filings

    View All

    SEC Form SD filed by Rivian Automotive Inc.

    SD - Rivian Automotive, Inc. / DE (0001874178) (Filer)

    5/29/26 4:33:37 PM ET
    $RIVN
    Auto Manufacturing
    Industrials

    SEC Form S-8 filed by Northwest Bancshares Inc.

    S-8 - Northwest Bancshares, Inc. (0001471265) (Filer)

    5/29/26 4:18:43 PM ET
    $NWBI
    Major Banks
    Finance

    SEC Form S-8 filed by Northwest Bancshares Inc.

    S-8 - Northwest Bancshares, Inc. (0001471265) (Filer)

    5/29/26 4:15:26 PM ET
    $NWBI
    Major Banks
    Finance

    $NTHI
    $NWBI
    $RIVN
    $SRAD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Hunter Timothy M bought $139,675 worth of Northwest Bancshares (10,000 units at $13.97), increasing direct ownership by 5% to 199,751 units (SEC Form 4)

    4 - Northwest Bancshares, Inc. (0001471265) (Issuer)

    5/28/26 10:05:17 AM ET
    $NWBI
    Major Banks
    Finance

    Director Gomez Aidan N. covered exercise/tax liability with 3,752 shares and bought $251,460 worth of shares (18,000 units at $13.97), increasing direct ownership by 36% to 54,232 units (SEC Form 4) to satisfy withholding obligation

    4 - Rivian Automotive, Inc. / DE (0001874178) (Issuer)

    5/19/26 7:24:31 PM ET
    $RIVN
    Auto Manufacturing
    Industrials

    Chief Executive Officer Koerl Carsten bought $2,128,735 worth of Class A Ordinary Shares (157,801 units at $13.49), increasing direct ownership by 6% to 2,776,073 units (SEC Form 4)

    4 - Sportradar Group AG (0001836470) (Issuer)

    5/7/26 4:10:34 PM ET
    $SRAD
    Computer Software: Programming Data Processing
    Technology

    $NTHI
    $NWBI
    $RIVN
    $SRAD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Sportradar Group AG downgraded by Analyst with a new price target

    Analyst downgraded Sportradar Group AG from Overweight to Neutral and set a new price target of $16.00

    5/27/26 8:41:16 AM ET
    $SRAD
    Computer Software: Programming Data Processing
    Technology

    Alliance Global Partners initiated coverage on NeOnc Technologies Holdings with a new price target

    Alliance Global Partners initiated coverage of NeOnc Technologies Holdings with a rating of Buy and set a new price target of $13.00

    5/19/26 8:31:51 AM ET
    $NTHI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Maxim Group initiated coverage on NeOnc Technologies Holdings with a new price target

    Maxim Group initiated coverage of NeOnc Technologies Holdings with a rating of Buy and set a new price target of $20.00

    5/18/26 8:44:12 AM ET
    $NTHI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $NTHI
    $NWBI
    $RIVN
    $SRAD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Sportradar Nets Official Wimbledon Tennis Data and AV Betting Rights Deal

    ST. GALLEN, Switzerland and LONDON, June 04, 2026 (GLOBE NEWSWIRE) -- Sportradar Group AG (NASDAQ:SRAD), a leading global sports technology company creating immersive experiences for sports fans and bettors, today announced a multi-year extension of its data and audiovisual (AV) betting rights agreement for The Championships, Wimbledon. The rights were originally secured as part of the company's acquisition of IMG ARENA in 2025. The multi-year renewal of the agreement beyond 2026 with the All England Club, which stages Wimbledon, continues Sportradar's exclusive global distribution of official data and AV betting rights. The agreement covers both The Championships main draw and the Qualif

    6/4/26 4:30:00 AM ET
    $SRAD
    Computer Software: Programming Data Processing
    Technology

    The Multi-Billion-Dollar Search for Better Glioblastoma Treatments

    DENVER, June 03, 2026 (GLOBE NEWSWIRE) -- (www.247marketnews.com) – Cancer treatment has advanced dramatically over the past two decades. Precision medicine, immunotherapy, antibody-drug conjugates, and targeted therapies have transformed outcomes for patients across multiple tumor types. Yet one of oncology's greatest challenges remains largely unsolved. Glioblastoma. Despite billions of dollars invested in research and development, glioblastoma remains one of the deadliest forms of cancer, with patients often facing limited treatment options and poor long-term survival rates. The disease's aggressive nature, combined with the difficulty of delivering therapies into the brain, has mad

    6/3/26 9:28:24 AM ET
    $BNTX
    $IBRX
    $KZIA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    Lilly's Cancer Bombshell Sparks Hunt for the Next Oncology Stock Set to Explode

    DENVER, June 01, 2026 (GLOBE NEWSWIRE) -- (www.247marketnews.com) – Eli Lilly (NYSE:LLY) has once again captured the attention of the oncology community after reporting remarkably strong Phase 3 results for Retevmo (selpercatinib) in early-stage RET fusion-positive non-small cell lung cancer. The LIBRETTO-432 study demonstrated an 83% reduction in the risk of disease recurrence or death versus placebo, potentially establishing Retevmo as a new standard of care in the adjuvant setting. The data were selected for presentation during the prestigious Plenary Session at the 2026 ASCO Annual Meeting and will be simultaneously published in The New England Journal of Medicine. For investors, the

    6/1/26 9:05:00 AM ET
    $LLY
    $NTHI
    $OLMA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $NTHI
    $NWBI
    $RIVN
    $SRAD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Felenstein Craig was granted 39,583 units of Class A Ordinary Shares, increasing direct ownership by 19% to 243,656 units (SEC Form 4) (withholding obligation)

    4 - Sportradar Group AG (0001836470) (Issuer)

    6/3/26 5:00:25 PM ET
    $SRAD
    Computer Software: Programming Data Processing
    Technology

    Chief Financial Officer Mcdonough Claire sold $128,368 worth of shares (8,023 units at $16.00) as part of a pre-agreed trading plan, decreasing direct ownership by 0.90% to 887,007 units (SEC Form 4)

    4 - Rivian Automotive, Inc. / DE (0001874178) (Issuer)

    6/2/26 4:20:41 PM ET
    $RIVN
    Auto Manufacturing
    Industrials

    Chief Executive Officer Scaringe Robert J sold $522,270 worth of shares (34,818 units at $15.00) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 922,286 units (SEC Form 4)

    4 - Rivian Automotive, Inc. / DE (0001874178) (Issuer)

    5/29/26 4:33:07 PM ET
    $RIVN
    Auto Manufacturing
    Industrials

    $NTHI
    $NWBI
    $RIVN
    $SRAD
    Leadership Updates

    Live Leadership Updates

    View All

    Sportradar Appoints Sameer Deen as Chief Operating Officer

    ST. GALLEN, Switzerland, April 28, 2026 (GLOBE NEWSWIRE) -- Sportradar Group AG (NASDAQ:SRAD)("Sportradar" or the "Company"), a leading global sports technology company focused on creating immersive experiences for sports fans and bettors, today announced that gaming and digital industry executive Sameer Deen has been named Chief Operating Officer (COO) of the Company, effective May 18, 2026. He will report directly to Sportradar's Chief Executive Officer, Carsten Koerl. In his role as COO, Mr. Deen will oversee Commercial and Group Operations while collaborating closely with the executive leadership team to advance the organization's strategy and growth. With a unique blend of strategic

    4/28/26 7:07:00 AM ET
    $SRAD
    Computer Software: Programming Data Processing
    Technology

    NeOnc Technologies Appoints David Choi as Chief Accounting Officer

    CALABASAS, Calif., March 13, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NASDAQ:NTHI) ("NeOnc" or the "Company"), a multi-Phase 2 clinical-stage biopharmaceutical company developing novel therapies for central nervous system (CNS) cancers, has appointed David Choi as Chief Accounting Officer. In this role, Mr. Choi is responsible for overseeing the Company's accounting, financial reporting, internal controls, and corporate governance functions as NeOnc advances its clinical-stage biotechnology platform and expands its global operations. "David's extensive expertise in technical accounting and financial reporting for public companies comes at a pivotal time for NeOnc," said

    3/13/26 9:00:00 AM ET
    $NTHI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Rivian Hires Greg Revelle as Chief Customer Officer

    Revelle Brings Deep Experience in eCommerce and Marketing to American Automaker Rivian (NASDAQ:RIVN) today announced the appointment of Greg Revelle to Chief Customer Officer (CCO) of Rivian. Revelle joins Rivian from Revatek, a startup he founded dedicated to enhancing the off-grid outdoor experience through innovative energy storage. He has also held leadership roles at Kohl's, Best Buy, AutoNation and Expedia, in addition to being a current board member at Cars.com. Beginning today, Revelle will oversee the entirety of the customer journey at Rivian, leading its go-to-market strategy, including sales, marketing and operations. "We are excited that Greg is bringing his deep experience

    1/12/26 9:27:00 AM ET
    $RIVN
    Auto Manufacturing
    Industrials

    $NTHI
    $NWBI
    $RIVN
    $SRAD
    Financials

    Live finance-specific insights

    View All

    NeOnc Provides Business Update and Reports Q1 2026 Financial Results

    CALABASAS, Calif., May 18, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NASDAQ:NTHI) ("NeOnc" or the "Company"), a clinical-stage biopharmaceutical company advancing two Phase 2 programs in central nervous system (CNS) cancers, today announced financial results for the first quarter ended March 31, 2026, and provided an update on recent operational achievements and upcoming milestones. Amir Heshmatpour, Chief Executive Officer, Executive Chairman, and President, commented: "The first quarter of 2026 marked a transformational period for NeOnc as we advanced both of our lead clinical programs toward important regulatory and value-creation milestones. We successfully comp

    5/18/26 9:00:00 AM ET
    $NTHI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Sportradar Reports First Quarter 2026 Financial Results and Announces $250 Million Enhanced Open Market Share Repurchase Program

    First Quarter 2026 Highlights Revenue increased 11% to €347 millionLoss for the period of €6 million, 1.8% as a percentage of revenue with increased operating results offset by unrealized foreign currency lossesAdjusted EBITDA1 increased 12% to €66 million and Adjusted EBITDA margin1 expanded to 19.0%Net cash from operating activities of €109 million. Free cash flow1 increased 38% to €44 millionAchieved a Customer Net Retention Rate1 of 108% excluding contributions from IMGRepurchased $90 million of shares under the share repurchase plan and announced a $250 million enhanced open market share repurchase programAnnounced Sameer Deen to join Sportradar leadership team as Chief Operating Offic

    4/28/26 7:00:00 AM ET
    $SRAD
    Computer Software: Programming Data Processing
    Technology

    Northwest Bancshares, Inc. Announces First Quarter 2026 GAAP net income of $51 million, or $0.34 per diluted share

    Adjusted net income (non-GAAP) of $51 million, or $0.35 per diluted shareNet interest margin continues to expand to 3.70%28% average commercial and industrial loan growth from prior yearCredit quality remained strong with annualized net charge-offs of 0.16% and nonperforming assets of 0.70%COLUMBUS, Ohio, April 27, 2026 /PRNewswire/ -- Northwest Bancshares, Inc., (the "Company"), (NASDAQ:NWBI) announced net income for the quarter ended March 31, 2026 of $51 million, or $0.34 per diluted share. This represents an increase of $7 million compared to the same quarter last year, when net income was $43 million, or $0.34 per diluted share, and an increase of $5 million compared to the prior quarte

    4/27/26 4:05:00 PM ET
    $NWBI
    Major Banks
    Finance

    $NTHI
    $NWBI
    $RIVN
    $SRAD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Sportradar Group AG

    SC 13G/A - Sportradar Group AG (0001836470) (Subject)

    11/14/24 6:11:06 PM ET
    $SRAD
    Computer Software: Programming Data Processing
    Technology

    SEC Form SC 13G filed by Rivian Automotive Inc.

    SC 13G - Rivian Automotive, Inc. / DE (0001874178) (Subject)

    10/7/24 7:12:50 PM ET
    $RIVN
    Auto Manufacturing
    Industrials

    SEC Form SC 13G/A filed by Rivian Automotive Inc. (Amendment)

    SC 13G/A - Rivian Automotive, Inc. / DE (0001874178) (Subject)

    6/7/24 1:30:03 PM ET
    $RIVN
    Auto Manufacturing
    Industrials